Lafora disease due to EPM2B mutations: A clinical and genetic study

Neurology

Volumn 64, Issue 6, 2005, Pages 982-986

  Gomez Abad C ^a   Gomez Garre P ^a   Gutierrez Delicado E ^a   Saygi, S ^b   Michelucci, R ^c   Tassinari, C A ^c   Rodriguez De Cordoba S ^d   Serratosa, J M ^a,e  

^a Fund Jiménez Díaz   (Spain)

^b HACETTEPE UNIVERSITY   (Turkey)

^c BELLARIA HOSPITAL   (Italy)

^d CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

^e Fund Jiménez Díaz   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID;

ADULT; ARTICLE; BASE PAIRING; CONTROLLED STUDY; EPM2A GENE; EPM2B GENE; GENE; GENE DELETION; GENE MUTATION; GENOTYPE; HUMAN; MUTATIONAL ANALYSIS; MYOCLONUS EPILEPSY; NONSENSE MUTATION; PHENOTYPE; PRIORITY JOURNAL;

EID: 15244352202     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000154519.10805.F7     Document Type: Article

References (20)

1. Van Heycop Ten Ham MW. Lafora disease, a form of progressive myoclonus epilepsy. In: Vinken PJ, Bruyn GW, eds. The epilepsies: Handbook of clinical neurology, vol 15. North-Holland, Amsterdam: Elsevier, 1975:382-422.
2. Lafora GR. Über das Vorkommen amyloider Körperchen im Innern der Ganglienzellen; zugleich ein zum Studium der amyloiden Substanz im Nervensystem. Virchows Arch [Pathol Anat] 1911;205:295-303.
3. Lafora GR, Glueck B. Beitrag zur Histopathologie der myoklonischen Epilepsie. Z. Gesamte Neurol Psychiatr 1911;6:1-14.
4. Yokoi S, Austin J, Witmer F, et al. Studies in myoclonus epilepsy (Lafora body forms). I. Isolation and preliminary characterization of Lafora bodies in two cases. Arch Neurol 1968;19:15-33.
5. Sakai M, Austin J, Witmer F, et al. Studies in myoclonus epilepsy (Lafora body form). II. Polyglucosans in the systemic deposits of myoclonus epilepsy and in corpora amylacea. Neurology 1970;20:160-176.
6. Serratosa JM, Gomez-Garre P, Gallardo ME, et al. A novel protein tyrosine phosphatase gene is mutated in progressive myoclonus epilepsy of the Lafora type (EPM2). Hum Mol Genet 1999;8:345-352.
7. Minassian BA, Lee JR, Herbrick JA, et al. Mutations in a gene coding a novel protein tyrosine phosphatase cause a progressive myoclonus epilepsy. Nat Genet 1998;20:171-174.
8. Chan EM, Young EJ, Ianzano L, et al. Mutations in NHLRC1 cause progressive myoclonus epilepsy. Nat Genet 2003;35:125-127.
9. Tassinari CA, Bureau-Paillas M, Dalla-Bernardina B, et al. La maladie de Lafora. Rev EEG Neurophysiol 1978;8:107-122.
10. Shirozu M, Hashimoto M, Tomimatsu M, Nakazawa Y, Anraku S, Nagata M. Lafora disease diagnosed by skin biopsy. Kurume Med J 1985;32:311-313.
11. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning. A laboratory manual, 2nd ed. New York: Cold Spring Harbor Laboratory Press, 1989.
12. Orita M, Iwahana H, Kanazawa H, et al. Detection of polymorphism of human DNA by gel electrophoresis as single-strand conformation polymorphism. Proc Natl Acad Sci USA 1989;86:2766-2770.
13. Ganesh S, Delgado-Escueta AV, Suzuki T, et al. Genotype-phenotype correlations for EPM2A mutations in Lafora's progressive myoclonus epilepsy: exon 1 mutations associate with an early-onset cognitive deficit subphenotype. Hum Mol Genet 2002;11:1263-1271.
14. Annesi G, Sofia V, Gambardella A, et al. A novel exon 1 mutation in a patient with atypical lafora progressive myoclonus epilepsy seen as childhood-onset cognitive deficit. Epilepsia 2004;45:294-295.
15. Slack FJ, Ruvkun G. A novel repeat domain that is often associated with RING finger and B-box motifs. Trends Biochem Sci 1998;23:474-475.
16. Wang J, Stuckey JA, Wishart MJ, Dixon JE. A unique carbohydrate binding domain targets the lafora disease phosphatase to glycogen. J Biol Chem 2002;277:2377-2380.
17. Fernandez-Sanchez ME, Criado-Garcia O, Heath KE, et al. Laforin, the dual-phosphatase responsible for Lafora disease, interacts with R5 (PTG), a regulatory subunit of protein phosphatase-1 that enhances glycogen accumulation. Hum Mol Genet 2003;12:3161-3171.
18. Freemont PS. The RING finger. A novel protein sequence motif related to the zinc finger. Ann NY Acad Sci 1993;684:174-192.
19. Hochstrasser M. Ubiquitin-dependent protein degradation. Annu Rev Genet 1996;30:405-439.
20. Pickart CM. Mechanisms underlying ubiquitination. Annu Rev Biochem 2001;70:503-533.